🔗 Permalink

Inventor profile of:

David Robert Micklem

City:

Bergen

Country:

Norway

Published Applications:

Last publication date:

2024-06-13

Top Assignees for applications by David Robert Micklem

The entities that hold a legal rights for patent applications filed by inventor Micklem David Robert:

BerGenBio ASA 10 Bergen, Norway
BERGEN TEKNOLOGIOVERFØRING AS 5 Bergen, Norway
BerGenBio AS 5 BERGEN, Norway
Bergen Teknologioverforing AS 3 Bergen, Norway
Bergen Teknologioverføring AS 1 Thormøhlensgate, Norway
BerGenBio ASA 1 Jonas Lies vei, Norway
BERGEN TEKNOLOGIOVERFORING AS 1 Stedkode, Norway
Bergen Teknologioverforing AS 1 Stedkode 70900, Norway
BERGEBIO ASA 1 Bergen, Norway

Recent patent applications by Micklem David Robert

David Robert Micklem from Bergen, NO has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-06-13

US20240190972A1

Chemistry; metallurgy

Anti-Axl Antagonistic Antibodies

#2 | 2023-12-21

US20230406941A1

Chemistry; metallurgy

Anti-AXL Antagonistic Antibodies

#3 | 2022-06-23

US20220195054A1

Chemistry; metallurgy

Anti-axl antagonistic antibodies

#4 | 2022-06-16

US20220185897A1

Chemistry; metallurgy

ANTI-AXL ANTIBODIES

#5 | 2021-06-10

US20210171643A1

Chemistry; metallurgy

Anti-Axl antagonistic antibodies

#6 | 2019-06-13

US20190177419A1

Chemistry; metallurgy

Anti-Axl antagonistic antibodies

#7 | 2018-12-27

US20180371096A1

Chemistry; metallurgy

Anti-Axl antibodies

#8 | 2018-08-30

US20180246080A1

Physics

METHODS USING AXL AS A BIOMARKER OF EPITHELIAL-TO-MESENCHYMAL TRANSITION

#9 | 2018-07-26

US20180208989A1

Chemistry; metallurgy

Biomarkers for cancer

#10 | 2017-12-07

US20170349658A1

Chemistry; metallurgy

Anti-Axl antagonistic antibodies

#11 | 2017-11-02

US20170314077A1

Chemistry; metallurgy

SLFN11 AS BIOMARKER FOR AML

#12 | 2017-05-11

US20170129957A1

Chemistry; metallurgy

Anti-Axl antibodies

#13 | 2017-04-20

US20170107290A1

Chemistry; metallurgy

Anti-Axl antibodies

#14 | 2016-11-24

US20160339021A1

Human necessities

Use of kinase inhibitors

#15 | 2015-07-30

US20150212065A1

Physics

Methods using Axl as a biomarker of epithelial-to-mesenchymal transition

#16 | 2012-06-21

US20120159655A1

Physics

METHODS USING AXL AS A BIOMARKER OF EPITHELIAL-TO-MESENCHYMAL TRANSITION

InventorID:

1241121 ⎘